The incidence of kaposi sarcoma among injection drug users with AIDS in the United States

Journal of Acquired Immune Deficiency Syndromes

Volumn 37, Issue 2, 2004, Pages 1282-1287

  Atkinson, Jonnae O ^a   Biggar, Robert J ^a   Goedert, James J ^a   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AIDS; Cancer; Epidemiology; Human herpesvirus 8 (Kaposi sarcoma associated herpesvirus); Injection drug use; Kaposi sarcoma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GEOGRAPHIC DISTRIBUTION; HETEROSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; INCIDENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 4644298709     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000120807.43677.b6     Document Type: Article

References (26)

1. Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
2. Schulz TF. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis. J Antimicrob Chemother. 2000; 45(suppl T3):15-27.
3. Martin JN, Ganem DE, Osmond DH, et al. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998;338: 948-954.
4. Renwick N, Halaby T, Weverling GJ, et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS. 1998;12:2481-2488.
5. Beral V, Peterman TA, Berkelman RL, et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990;335: 123-128.
6. Hoover DR, Black C, Jacobson LP, et al. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol. 1993;138:266-278.
7. Lifson AR, Darrow WW, Hessol NA, et al. Kaposi's sarcoma in a cohort of homosexual and bisexual men: epidemiology and analysis for cofactors. Am J Epidemiol. 1990;131:221-231.
8. Jones JL, Hanson DL, Dworkin MS, et al. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;24:270-274.
9. Kedes DH, Operskalski E, Busch M, et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma- associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996;2:918-924.
10. Smith NA, Sabin CA, Gopal R, et al. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis. 1999;180:600-606.
11. Atkinson J, Edlin BR, Engels EA, et al. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis. 2003; 187:974-981.
12. Cannon MJ, Dollard SC, Smith DK, et al. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med. 2001;344:637-643.
13. Goedert JJ, Charurat M, Blattner WA, et al. Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. AIDS. 2003;17:425-433.
14. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92:1500-1510.
15. Greenblatt RM, Jacobson LP, Levine AM, et al. Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women. J Infect Dis. 2001;183:1130-1134.
16. Bernstein KT, Jacobson LP, Jenkins FJ, et al. Factors associated with human herpesvirus type 8 infection in an injecting drug user cohort. Sex Transm Dis. 2003;30:199-204.
17. Diamond C, Thiede H, Perdue T, et al. Seroepidemiology of human herpesvirus 8 among young men who have sex with men. Sex Transm Dis. 2001;28:176-183.
18. Renwick N, Dukers NH, Weverling GJ, et al. Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996. J Infect Dis. 2002;185:1808-1812.
19. Gambus G, Bourboulia D, Esteve A, et al. Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS. 2001;15:1167-1174.
20. Rezza G, Lennette ET, Giuliani M, et al. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer. 1998;77:361-365.
21. Perna AM, Bonura F, Vitale F, et al. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol. 2000;29:175-179.
22. Mbulaiteye SM, Biggar RJ, Bakaki PM, et al. Human herpesvirus 8 infection and transfusion history in children with sickle cell disease in Uganda. J Natl Cancer Inst. 2003;95:1330-1335.
23. Goedert JJ, Vitale F, Lauria C, et al. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst. 2002;94:1712-1718.
24. Richter KP, Ahluwalia HK, Mosier MC, et al. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction. 2002;97:861-869.
25. Do AN, Hanson DL, Dworkin MS, et al. Risk factors for and trends in gonorrhea incidence among persons infected with HIV in the United States. AIDS. 2001;15:1149-1155.
26. Astemborski J, Vlahov D, Warren D, et al. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health. 1994;84:382-387.